Nogo-A has been demonstrated to be over-expressed in the skeletal muscle of ALS subjects, and has been proposed as both an early diagnostic biomarker of ALS, and a surrogate of disease severity [10] [11] [12]. Here, RTN4 is linked to amyotrophic lateral sclerosis.